Vaccine for 12-14 year olds: Corbevax trial data to be out soon, says central panel chief
India Today
Starting tomorrow, children in the 12-14 age group will be administered vaccines against coronavirus.
The trial data of Corbevax will be released soon, National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora told India Today TV, stressing that the vaccine is safe and that authorities have looked into the data. Starting tomorrow, children in the 12-14 age group will be administered vaccines against coronavirus.
“We have included children with co-morbidities in this category since it was difficult to track and identify co-morbid children separately,” he said.
The Centre has also announced that everyone above the age of 60 will be given a precautionary shot of the vaccine from tomorrow. “Covaxin will be used as the precautionary dose for those 60 and above,” NK Arora said, adding, “There is also an issue of production of the vaccine.”
Also Read: | Experts divided as Centre announces vaccines for 12-14 age group
NTAGI members are divided over the government’s recommendation for vaccines for children below 15. Dismissing this, NK Arora said, “It’s nothing like that. A recommendation was given three months back and co-morbid children need to be protected since we are seeing a surge in cases once again. Our decisions are in line with the World Health Organisation’s guidelines.”
NTAGI is looking into precautionary doses for 45 years and above. “But, you will have to wait a little,” he said.
